The present invention relates to pharmaceutics compositions of 2-Methyl-4'- trifluoromethoxy-biphenyl-3-carboxylic acid [6-{cis-2,6-dimethyl-morpholin-4-yl)-pyridlin-3-yl]- amide, to the use of such compositions in therapeutic applications and to methods for manufacturing such compositions.